Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MAS063DP

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Proven as effective acne scar treatment, ablative fractional carbon dioxide (AFCO2 ) laser requires post-laser wound healing care… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
Review
2016
Review
2016
Although some symptoms of dermatologic diseases, such as pruritus and pain, can be subjectively assessed only by patients, the… Expand
Is this relevant?
2009
2009
Boguniewicz M, Zeichner JA, Eichenfield LF, et al. J Pediatr . 2008;152(6):854–859 PURPOSE OF THE STUDY. To examine the safety… Expand
Is this relevant?
2009
2009
Streszczenie Przedmiot Analiza skuteczności i bezpieczenstwa kremu MAS063DP (Atopiclair) w leczeniu lagodnych i umiarkowanych… Expand
Is this relevant?
2008
2008
A multicenter, randomized, double-blind, vehicle-controlled clinical study was conducted to evaluate the efficacy and safety of… Expand
  • table 1
  • table 2
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2008
2008
OBJECTIVE To examine the efficacy and safety of MAS063DP (Atopiclair) cream in the management of mild to moderate atopic… Expand
  • figure 1
Is this relevant?
2008
2008
Background: MAS063DP (Atopiclair™) is a topical cream approved for symptomatic relief in the treatment of atopic and contact… Expand
Is this relevant?
2006
2006
BACKGROUND MAS063DP cream has received marketing authorization in the US and the European Union for symptom relief of atopic… Expand
Is this relevant?